We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -1.49% | 16.50 | 16.00 | 17.00 | 16.75 | 16.50 | 16.75 | 169,683 | 14:04:40 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.81 | 15.05M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/7/2017 13:23 | BST 27P just might catch you guys up.! TOM has it down as his share of the year, and even quotes OPTI as a Reynolds stock that has done very well. Good luck here | pet lover | |
11/7/2017 13:19 | I think Mr 10k is splitting some into 5k's perhaps to increase the selling pressure | onedayrodders | |
11/7/2017 13:05 | It is a curse in a way , but I am right about 80% of the time, and so far today I have been on this one. Check out who paid the experienced panellists Then check out what their experience was in This RNS has no meaning ... it just says what 10 people thought about a taste experience .... and 10 people as a sample size is riduclous. The market has taken a dim view of it. Spike_111 Jul '17 - 10:22 - 24777 of 24792 4 1 buywell - you are pathetic! | buywell3 | |
11/7/2017 13:05 | It is a curse in a way , but I am right about 80% of the time, and so far today I have been on this one. Check out who paid the experienced panellists Then check out what their experience was in This RNS has no meaning ... it just says what 10 people thought about a taste experience .... and 10 people as a sample size is riduclous. The market has taken a dim view of it. Spike_111 Jul '17 - 10:22 - 24777 of 24792 4 1 buywell - you are pathetic! buywell3 - 11 Jul 2017 - 08:10:01 - 24757 of 24795 OptiBiotix - Better Science, Better Health. Better buy some! - OPTI What bothers me about this is the lack of institutional investors on board Plus the company has only 8 employees, and is thus very BOD top heavy The majority of shareholders are thus Mr and Mrs J Bloggs. My 60p call nearly got hit .... todays news gives some a chance to bail. | buywell3 | |
11/7/2017 12:55 | I'm waiting for news on Tata before I sell in the next few months. Worried about the mad scramble to sell which is going to come. | rickyvee | |
11/7/2017 12:55 | as expected I think we are going to end up red again on another excellent RNS albeit without £'s | onedayrodders | |
11/7/2017 12:53 | anyone worked out what you press to get an order and checkout ? I cant fathom it out on that website | onedayrodders | |
11/7/2017 12:37 | Good spot Andy! Looks like LP-LDL has replaced AB-LIFE's product for their LDL-Control capsules: From the website: characteristics Reduction of the cholesterol value by up to 36.7% increased cholesterol levels naturally do not have any side effects Lactobact® LDL-Control is able to effectively reduce the cholesterol level in the blood. This results in a positive effect on the entire cardiovascular system, as the risk of developing arteriosclerosis and associated cardiovascular disease is reduced. Lactobact® LDL-Control is a natural preparation with no side effects, which often occur in conventional therapies with cholesterol-lowering drugs. Therefore, it is also recommended for long-term use. The clinical study of the active substance in Lactobact® LDL-Control has shown that the LDL cholesterol level is reduced by more than 36.7% within a period of only 3 months by the regular daily intake of 1 capsule of this preparation. The preparation ensures that more cholesterol is excreted directly through the intestine and does not enter the body's cholesterol circulation. As a result, the concentration of the blood cholesterol and thus also the negative effect on our cardiovascular system is significantly reduced. Through a cholesterol-consciou | parob | |
11/7/2017 12:36 | Well,well,well. A big announcement on sugars and the first sales in Germany. | mrjohngalt | |
11/7/2017 12:27 | Cheers Andy If I'm reading this right then 90 capsules for around £17 is good value and only double what I'm paying for my Simvastatin. Of course it will need to keep my Cholesterol levels down. I'm going to speak with my doctor about coming off statins, using LP-LDL and monitoring my cholesterol levels. I'll keep you posted. | onedayrodders | |
11/7/2017 12:25 | what's the good of it, re 24787 to people here, get it in the shops in UK and Asia and USA as well as Germany. Can now sell a few at 63.2 and forget 67, top ups available at 64.2. | neftanikoff | |
11/7/2017 12:20 | See OPTI and the perma bulls still spouting the same jam tomorrow BS.I've come to the conclusion that the science here is not as ground breaking as first envisaged. Similar products already in a saturated market and it's all jam tomorrow BS.Also no real appetite for companies products.No real revenue generating products No demand from II investors.Even the perma bulls will wake up soon.By then it will be too late.Just another fluff AIM company.AIMHO | talkingtrade | |
11/7/2017 12:04 | LP-LDL launched and available to buy at HLH: www.hlh-biopharma.de | andyhayward1990 | |
11/7/2017 11:50 | I personally have got to sell some opti shares within the next 2 months for personal reasons and was (there is that word again) HOPING to get at least 85p and was fully expecting this price in view of what was i expecting, well some big orders with detail along withpartner news and sbtx share distribution news and considering it was 85p on April 1st and Tom W was merrily forecasting over 100p by Easter and even the company were talking about exciting things were happening and contracts being drafted and 30 companies showing interest. At the moment, with lack of news on the subjects that i had thought i was going to hear about, i somehow think that i may have been let up the gareden path and am likely not to be the only one feeling this way. | neftanikoff | |
11/7/2017 11:36 | I have checked again the actual price, which is 64.3 to buy down from an actual buy of almost 67p earlier this morning and still the system will not let me do a dummy sell for any amount. No doubt some of the lth bulls will say no need to worry, eventually the market will catch up with plenty of news in the coming weeks/months and so if you believe in the company go away for the time being. or if youy are that concerned, get phone your broker. For realism, perhaps it is best to listen to another lth, someone like John Henry and his post 24,763 says that actual deals may not be sealed (or he actually said significant revenues) for possibly another 12 months, are you being a bit pessimitic there John, i hope you are. | neftanikoff | |
11/7/2017 11:34 | Gotta say that I'm also disappointed with the share price reaction today. Which genuine holder wouldnt be? I think all those who are in for the long haul are fully loaded and the impatient are selling (inc Mr 10k) Hense the sellers are still firmly in control Firm figures and fresh deals are needed to change that. And it will happen. Thats for sure :) SBTX distribution news wouldnt go amiss either | judijudi | |
11/7/2017 11:06 | End of the year Del Boy. | colinzeal | |
11/7/2017 11:02 | at the end of the year or today colin ? ;o) | onedayrodders | |
11/7/2017 10:59 | I have to say I'm growing slightly impatient here - appreciate Rome wasn't built in a day but it's looking overvalued at £50 million with little to no income or any figures of potential revenue whatsoever. I'll reassess at the end of the year. | colinzeal | |
11/7/2017 10:39 | Was it not awesome news when the cholesterol trial was completed? How long ago was that? That was in fact September 2015 (RNS sept 29th 2015)and still no sales. Not far off two years later and still waiting. | imnotlong | |
11/7/2017 10:38 | Positive but it's more PR fluff than news that's going to push OPTI forward. What the markets want to see is the colour of money. | rollthedice | |
11/7/2017 10:32 | Awesome news The response underlines the poor "investor" make up of AIM in general | onedayrodders | |
11/7/2017 10:22 | buywell - you are pathetic! | spike_1 | |
11/7/2017 09:59 | ''The study used a trained expert panel of ten experienced panellists'' Who do you think paid the 10 experienced panellists ? What were they experienced in ? dominoes or tiddlywinks ? | buywell3 | |
11/7/2017 09:58 | In case you missed it:The study used a TRAINED EXPERT PANEL of ten EXPERIENCED panellists. | parob |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions